Acute disseminated encephalomyelitis (ADEM) is a rare inflammatory disorder of the central nervous system that affects the brain and spinal cord. It occurs when the body’s immune system mistakenly attacks the myelin, the protective covering surrounding nerve fibers. The inflammation and damage to myelin can interfere with the normal transmission of nerve signals, resulting in a variety of neurological symptoms. ADEM usually develops suddenly and over a short period, often following an infection. It is more common in children and adolescents, although adults can also develop the condition. ADEM is considered a medical emergency because symptoms can progress rapidly and may include seizures, severe confusion, loss of consciousness, or coma. Prompt medical evaluation and treatment are important.
The term “acute disseminated encephalomyelitis” describes the nature of the condition:
Acute means that it develops relatively quickly.
Disseminated means that multiple areas of the central nervous system can be affected.
Encephalomyelitis refers to inflammation involving the brain and spinal cord.
ADEM typically causes inflammation in several areas of the brain and sometimes the spinal cord and optic nerves. This inflammation can damage myelin and produce neurological symptoms. Unlike some other demyelinating diseases, ADEM commonly occurs as a single episode. Most people who receive appropriate treatment recover well, although recovery may take weeks or months and some people can experience lasting neurological problems.
Symptoms of ADEM can vary depending on which parts of the brain and spinal cord are affected. They usually develop over hours to several days.
Common symptoms include:
Fever
Headache
Nausea and vomiting
Unsteadiness, poor coordination, or difficulty walking
Weakness of the arms or legs
Difficulty swallowing
Vision problems or double vision
Drowsiness or unusual sleepiness
Confusion or changes in behavior
Seizures
Loss of consciousness
Coma in severe cases
A key feature of ADEM is encephalopathy, meaning a significant change in mental status such as confusion, excessive sleepiness, reduced alertness, or behavioral changes.Symptoms can sometimes resemble those of other neurological conditions, including meningitis, encephalitis, multiple sclerosis, stroke, or certain infections. Therefore, medical evaluation is essential for an accurate diagnosis.
The exact cause of ADEM is not completely understood. In many cases, ADEM occurs after an infection, usually a viral infection.It is believed that an infection can trigger an abnormal immune response. Instead of targeting only the infectious organism, the immune system may mistakenly attack components of the central nervous system, including myelin. Possible triggers include:
Viral infections
Certain bacterial infections
Occasionally, vaccination
Historically, ADEM has been associated with infections such as measles, mumps, rubella, influenza, varicella, and other viral illnesses. However, vaccination-related ADEM is rare, and vaccines are an uncommon trigger compared with infections. In many patients, no definite preceding infection or trigger can be identified.
No. ADEM itself is not contagious. The immune-mediated inflammation that causes ADEM cannot be passed from one person to another. However, an infection that occurs before ADEM may itself be contagious.
ADEM can occur at any age, but it is seen more frequently in children and adolescents. The condition may develop in previously healthy individuals after an infection. Having a preceding infection does not mean that a person will develop ADEM; the condition remains rare.
There is no single test that can definitively diagnose ADEM. Doctors usually make the diagnosis by considering the person’s symptoms, medical history, neurological examination, and test results.
Magnetic resonance imaging (MRI) of the brain, and sometimes the spinal cord, is one of the most important investigations for ADEM. MRI may show areas of inflammation or demyelination in multiple regions of the central nervous system.
A lumbar puncture (spinal tap) may be performed to examine cerebrospinal fluid (CSF). The test can help identify inflammation and, importantly, help doctors rule out infections and other conditions that can produce similar symptoms.
Blood tests and additional investigations may be performed to look for infections, autoimmune disorders, metabolic problems, or other possible causes of the symptoms. In selected cases, doctors may also perform tests for specific antibodies, including myelin oligodendrocyte glycoprotein (MOG) antibodies, because MOG-associated disease can sometimes present with ADEM-like symptoms.
High-dose corticosteroids, such as intravenous methylprednisolone, are commonly used as the initial treatment for moderate to severe ADEM. Treatment is often followed by a gradual course of oral corticosteroids, depending on the patient’s clinical response and the treating physician’s assessment.
For severe cases that do not respond adequately to corticosteroids and IVIG, plasma exchange (plasmapheresis) may be considered. This treatment removes and replaces plasma components that may be contributing to the abnormal immune response.
The outlook for ADEM is generally good, particularly when the condition is recognized and treated promptly. Many patients begin improving within days or weeks after treatment, although complete recovery can take several months. Some people may temporarily experience:
Weakness
Problems with balance or coordination
Fatigue
Difficulty concentrating
Memory problems
Vision problems
A small proportion of patients may develop persistent neurological difficulties. Although ADEM is usually a one-time illness, recurrence can occur but is uncommon. If similar episodes occur repeatedly, doctors may investigate whether another demyelinating disorder, including MOG-associated disease or multiple sclerosis, may be responsible.
ADEM can progress rapidly and requires urgent medical assessment. Seek immediate medical attention if a person develops sudden neurological symptoms such as:
Confusion or a major change in behavior
Severe drowsiness or difficulty waking
New weakness in the arms or legs
Difficulty walking or severe loss of balance
Seizures
Significant vision problems
Difficulty swallowing
Loss of consciousness
These symptoms can also occur in other serious conditions, so emergency evaluation is important.
The primary specialist for ADEM is a: Neurologist
Children with ADEM may be evaluated by a pediatric neurologist. Depending on the symptoms and severity, treatment may also involve specialists in critical care, infectious diseases, rehabilitation, ophthalmology, or other relevant fields.
No. ADEM and multiple sclerosis (MS) are different conditions, although both can involve inflammation and damage to myelin. ADEM usually occurs as a single acute episode, particularly in children, whereas MS typically has a different pattern of disease activity and recurrence.
ADEM can often be successfully treated, and many patients recover substantially or completely. However, the recovery period varies from person to person, and some patients may have lasting neurological symptoms.
Most people experience only one episode. Recurrence is uncommon. Repeated episodes may require additional evaluation to determine whether another inflammatory or demyelinating disorder is present.
ADEM often occurs after an infection, particularly a viral infection. However, the infection itself does not directly cause the neurological damage in every case. The condition is believed to result from an abnormal immune response triggered by the infection.
ADEM has occasionally been reported after vaccination, but this is rare. Infections are a more common preceding trigger. Vaccination decisions should be discussed with a qualified healthcare professional rather than based on an individual case report or isolated association.
Acute disseminated encephalomyelitis (ADEM) is a rare but potentially serious inflammatory disorder in which the immune system attacks myelin in the brain and spinal cord. It often follows an infection and can cause fever, headache, confusion, weakness, balance problems, vision disturbances, seizures, and other neurological symptoms. Because ADEM can resemble other serious conditions and may progress rapidly, early medical evaluation is essential. Treatment, usually involving corticosteroids and other immune therapies when necessary, can lead to significant recovery in many patients.
Medical Disclaimer:This article is intended for general health information and education only. It should not be used to diagnose or treat ADEM or any other medical condition. Anyone experiencing sudden neurological symptoms should seek urgent medical care.
